Results 191 to 200 of about 102,302 (358)

Machine Learning Approach Enables Highly Accurate Identification of At‐Risk Metabolic Dysfunction‐Associated Steatohepatitis

Hepatology Research, EarlyView.
ABSTRACT Aim At‐risk metabolic dysfunction‐associated steatohepatitis (MASH), characterized by significant activity and fibrosis, increases the risk of liver complications. Liver stiffness measurement (LSM), commonly used to detect significant fibrosis, has limitations in terms of accessibility and performance in certain populations.
Masaya Sato, Takuma Nakatsuka, Tatsuya Minami, Yotaro Kudo, Rie Irie, Hanako Tsujikawa, Takumi Kawaguchi, Hirokazu Takahashi, Yuichiro Eguchi, Eisuke Murakami, Kazuaki Chayama, Takeshi Okanoue, Michiie Sakamoto, Mitsuhiro Fujishiro, Kazuhiko Koike, Ryosuke Tateishi   +15 more
wiley   +1 more source

Duration and Predictive Factors of Plastic Biliary Stent Patency: Results of a Large Prospective Database Analysis. [PDF]

J Clin Med
Dieninyte E, Jasiunas E, Lemezis A, Kezeviciute E, Stanaitis J, Poskus T.   +5 more
europepmc   +1 more source

Splenic artery aneurysms occurring in liver transplant recipients [PDF]

, 1991
Bronsther, O, Merhav, H, Starzl, TE, Van Thiel, D   +3 more
core   +1 more source

Epidemiology and Genetics of Rheumatic Diseases Suggest a Constant Rate of DNA Damage as Underlying Cause

Immunology, EarlyView.
A constant rate of DNA damage that is not perfectly repaired will cause a constant rate of DNA mutations. The chance of mutation will increase if DNA is prone to damage, such as occurs in somatic hypermutation (SHM) hotspots and GC‐rich DNA. Thus, if one mutation‐prone DNA site drives disease, the age of onset of disease and degree of penetrance should
Piet C. de Groen
wiley   +1 more source

Pembrolizumab-Induced Secondary Cholangitis: A Case Report. [PDF]

Cureus
Muhd Opandi NA, Ahmed A, Robinson E, Abdulrehman A.   +3 more
europepmc   +1 more source

Bacterial Extracellular Vesicles in the Pathogenesis and Treatment of Liver Diseases

Journal of Gastroenterology and Hepatology, EarlyView.
Liver diseases are a major global health challenge, with current treatments inadequate. This review highlights the role of bacterial extracellular vesicles in liver inflammation, fibrosis, and metabolism. We also explore these from commensals and probiotics, their protective effects, and discuss research challenges and future therapeutic potential ...
Yakun Li, Jia Li, Robin P. F. Dullaart, Han Moshage   +3 more
wiley   +1 more source

Editorial: Leveraging multi-omics approaches to understand and manage gastrointestinal and hepatic diseases

Frontiers in Pharmacology
Isis Trujillo-Gonzalez, Isis Trujillo-Gonzalez, Paul G. Thomes, Isin Tuna Sakallioglu, Kusum K. Kharbanda, Kusum K. Kharbanda, Kusum K. Kharbanda   +6 more
doaj   +1 more source

Drug-Induced Sclerosing Cholangitis Leading to Discontinuation of Treatment in a Patient with Metastatic Breast Cancer: A Case Report. [PDF]

Case Rep Oncol
Aso S, Shimomura A, Hirai H, Honda Y, Misumi K, Watadani T, Aso K, Kitagawa D, Shimizu C.   +8 more
europepmc   +1 more source

A case of cholestatic hepatitis associated with histologic features of acute cholangitis

, 2011
Hiroaki Yokomori
openalex   +2 more sources

A107 DISEASE DISTRIBUTION AND CLINICAL FEATURES OF INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS [PDF]

, 2019
K Donaldson, Robert Enns, Brian Bressler, Hin Hin Ko   +3 more
openalex   +1 more source